Sponsored content brought to you by
Deploying advanced research environments is complex, hence the need for collaboration. SmartLabs reduces the financial and operational risks for life science innovators – no matter their size, profile, development stage, or field of research – by providing integrated lab infrastructure and support services. By hosting and co-locating next generation drug discovery R&D laboratories, in vivo and cGMP manufacturing facilities in its Managed Research Centers (MRC) in Boston and other select biotech hubs, the company supports groundbreaking research under one roof.
SmartLabs recently launched its Custom Developed Solutions (CDS) platform, designed to deploy its laboratory solutions worldwide. This offering addresses the need for adaptable laboratory infrastructure globally by providing expert oversight and extensive support in the design, construction, operation, and marketing of state-of-the-art R&D facilities—regardless of location.
With CDS, the company collaborates with life science companies, landlords, REITs, academia, and public institutions that may lack the expertise, personnel, and/or other resources needed to build out or operate advanced research spaces. The goal is to deliver tailored solutions directly to an organization’s existing location, ensuring each project meets each partner’s unique needs. The approach opens up access to new markets and industries for local landlords interested in offering life sciences real estate solutions. It also helps biotech and biopharma companies remain competitive in a rapidly changing landscape by giving them the support they need to accommodate their teams in advanced lab environments and empower them with essential technical support.
“CDS expands SmartLabs’ offering with a flexible approach for clients globally. Instead of end-users having to come to one of our US Managed Research Centers, we can now go to them and deploy our expertise, knowledge, and ability to operate next generation laboratory spaces outside of our own walls. We can design, build, operate, and market entire research centers, either individually or as a complete package,” said Clement Fourny, SVP of Commercial at SmartLabs.
“Some customers prefer staying in control by owning their research infrastructure, but they need the expertise and skilled resources to bring their vision to life,” Fourny continued. “We can be that trusted partner and make advanced laboratory tools available to local innovators everywhere, following a range of flexible options. What sets us apart is our ability to offer maximum scalability and help scientists from various life sciences sectors through the entire R&D journey – from early discovery to the commercial phase – whether it is in our facilities, or theirs.”
The CDS platform follows the same approach as SmartLabs’ MRC model in that it is agnostic to the size, type, and development stage of resident life science companies. Under the CDS platform, however, customers will expand to include real estate developers, academic institutions, and public and private companies all over the world – with these CDS partners investing and owning the facilities. The company builds on its expertise and proven technology to design modular spaces that can be configured quickly to meet a client’s unique and evolving needs. In CDS facilities developed with local life sciences partners, lab spaces are tailored to the investor’s specifications and long-term strategy, with levels of programing that address current and future market demands – dry and wet labs, offices, vivariums, and more.
“While we can operate existing facilities worldwide or assist in the design and build of new greenfield projects, our recent global partnership with a major publicly traded real estate company now enables us to deliver the complete package anywhere in the world. Our ambition is to make SmartLabs’ solutions available to innovators with unmet needs in emerging and high-potential life sciences hubs globally,” emphasized Fourny. “This approach, offered under a franchise model, allows REITs and landlords to support the growth of their local life sciences ecosystem with a proven and scalable framework.”
By empowering property owners to convert offices into labs or develop new greenfield projects, scientists will have wider access to the tools and services they need to support cutting-edge research. More broadly, the CDS platform offers SmartLabs the opportunity to customize its programs based on the level of support requested locally, from the management of a specified service in existing facilities to offering integrated turnkey research centers.
“We can partner in many dimensions with biotech innovators and established industry players, but also with new investors who want to play a role in the life sciences industry,” said Fourny. “SmartLabs’ new CDS offering is designed to facilitate and advance innovation regardless of geographic location or field of research.”
To explore our solutions visit www.SmartLabs.com.
